Validation of the GATE Software
Completed
- Conditions
- Visual Field Defects
- Interventions
- Procedure: perimetry
- Registration Number
- NCT01265628
- Lead Sponsor
- University Hospital Tuebingen
- Brief Summary
Comparison of the differential luminance sensitivity (DLS) values at each test point
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- physical, intellectual and linguistic abilities, in order to understand the test requirements
- spherical ametropia max. ± 8 dpt, cylindrical ametropia max. ± 3 dpt
- distant visual acuity > 10/20
- isocoria, pupil diameter > 3 mm
Exclusion Criteria
- pregnancy, nursing
- diabetic retinopathy
- asthma
- HIV+ or AIDS
- history of epilepsy or significant psychiatric disease
- medications known to effect visual field sensitivity
- acute ocular infections (e.g. keratitis, conjunctivitis, uveitis)
- severe dry eyes
- miotic drugs
- amblyopia
- squint
- nystagmus
- albinism
- keratoconus
- intraocular surgery (except for uncomplicated cataract surgery) performed < 3 month prior to screening
- history or presence of macular disease and / or macular edema
- relevant opacities of central refractive media (cornea, lens, vitreous body)
- ocular trauma
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Glaucoma perimetry - Retinitis pigmentosa (RP) perimetry - Anterior Ischemic Optic Neuropathy (AION) perimetry -
- Primary Outcome Measures
Name Time Method Validation of visual field data and comparison of the differential luminance sensitivity (DLS) values at each test point by applying two perimetric software versions. up to 14 days each participant were examined 2 times at two seperate sessions within 14 days.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Centre for Ophthalmology, Institute for Ophthalmic Research
🇩🇪Tuebingen, Germany